Cannabix Technologies (FRA:8CT) Change In Receivables: €-0.01 Mil (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8CT Cannabix Technologies Inc FRA:8CT
40 GF Score
Price €0.30
! 2 Warning Signs
View Full Analysis

What is Cannabix Technologies Change In Receivables?

Cannabix Technologies FRA:8CT -3.90% 40 Change In Receivables is €-0.01 Mil as of Jan. 2026. GuruFocus rates FRA:8CT with a GF Score™ of 40/100. The stock has 2 warning signs investors should review.

Cannabix Technologies's change in receivables for the quarter that ended in Jan. 2026 was €0.04 Mil. It means Cannabix Technologies's Accounts Receivable declined by €0.04 Mil from Oct. 2025 to Jan. 2026 .

Cannabix Technologies's change in receivables for the fiscal year that ended in Apr. 2025 was €-0.02 Mil. It means Cannabix Technologies's Accounts Receivable increased by €0.02 Mil from Apr. 2024 to Apr. 2025 .

Cannabix Technologies's Accounts Receivable for the quarter that ended in Jan. 2026 was €0.03 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cannabix Technologies's Days Sales Outstanding for the three months ended in Jan. 2026 was 124.43.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cannabix Technologies's liquidation value for the three months ended in Jan. 2026 was €0.68 Mil.

Cannabix Technologies  (FRA:8CT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cannabix Technologies's Days Sales Outstanding for the quarter that ended in Jan. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.03/0.022*91
=124.43

2. In Ben Graham's calculation of liquidation value, Cannabix Technologies's accounts receivable are only considered to be worth 75% of book value:

Cannabix Technologies's liquidation value for the quarter that ended in Jan. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.778-0.158+0.75 * 0.03+0.5 * 0.072
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabix Technologies Change In Receivables Related Terms

Cannabix Technologies Change In Receivables Historical Data

* Premium members only.

The historical data trend for Cannabix Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabix Technologies Change In Receivables Chart

Cannabix Technologies Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 -0.02 -0.00 0.00 -0.02

Cannabix Technologies Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 0.02 -0.05 0.04
FRA:8CT
40GF Score
Cannabix Technologies Inc FRA:8CT
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannabix Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €-0.01 Mil mean?
Cannabix Technologies (FRA:8CT) has a Change In Receivables of €-0.01 Mil as of Jan. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Cannabix Technologies and its competitors.
Is Cannabix Technologies' Change In Receivables too high?
Cannabix Technologies' current Change In Receivables is €-0.01 Mil. Overall, Cannabix Technologies has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' Change In Receivables compare to ABT and SYK?
Cannabix Technologies' Change In Receivables of €-0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Cannabix Technologies and its competitors. Cannabix Technologies's current Change In Receivables is €-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (FRA:8CT) has a current Change In Receivables of €-0.01 Mil. The current Change In Receivables is €-0.01 Mil. Cannabix Technologies' overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Cannabix Technologies (FRA:8CT), the current Change In Receivables is €-0.01 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabix Technologies Business Description

Address 3292 Production Way, Suite 501, Burnaby, BC, CAN, V5A 4R4
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
40GF Score

Get the complete analysis for FRA:8CT

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price